S&P 500

5.652,30

0,37%

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

Startseite
Investieren
Aktien
USA
NASDAQ
Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)
Angiotech Pharmaceuticals - Common Shares (MM) (ANPI) News

ANPI

Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)

Angiotech Pharmaceuticals - Common Shares (MM)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ANPI

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
25/06/2009	18h41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
24/06/2009	13h33	Marketwired	TheFortuneFinancial.com Free Market Research on PXD, SHLD, LBTYA, INFY, ANPI and MXIM	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
23/06/2009	21h11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
23/06/2009	20h28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
23/06/2009	20h17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
23/06/2009	19h35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
19/06/2009	21h27	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
18/06/2009	19h55	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
12/06/2009	00h05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
11/06/2009	23h57	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
11/06/2009	23h50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
11/06/2009	23h43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
11/06/2009	23h33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
09/06/2009	16h24	PR Newswire (US)	Trade Alerts on Active Stocks: Apple, Keryx, Angiotech, General Mills, Pep Boys and Talbots; Issued by InvestorSoup.com	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
08/06/2009	14h30	PR Newswire (US)	Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
04/06/2009	16h10	PR Newswire (US)	Stock Alerts on Thursday's Active Industry Leaders; Issued by InvestorSoup.com	NASDAQ:ANPI
03/06/2009	16h47	PR Newswire (US)	Angiotech Enters License, Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
01/06/2009	15h08	Marketwired	WallStSense.com Free Research Report for Shareholders of NVDA, MXIM, ANPI and EXEL	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
29/05/2009	15h20	PR Newswire (US)	Beacon Equity Issues Stock Alerts on Leading Pharmaceutical Giants	NASDAQ:ANPI
27/05/2009	17h54	PR Newswire (US)	Angiotech Pharmaceuticals announces FDA approval of next-generation TAXUS(R) Liberte(R) Atom(TM) Stent system	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
20/05/2009	20h10	PR Newswire (US)	SYNTAX analysis finds treatment with TAXUS(R) Express(2)(R) Stent System more cost effective than bypass surgery in patients wit	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
19/05/2009	23h44	PR Newswire (US)	Angiotech's corporate partner, Boston Scientific, announces launch of third-generation TAXUS(R) Element(TM) Stent	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
19/05/2009	23h38	PR Newswire (US)	SYNTAX substudy shows positive outcomes for left main patients treated with TAXUS(R) Express(2)(R) Stent System	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
19/05/2009	14h30	PR Newswire (US)	Angiotech launches e-commerce website that allows customers to order Quill(TM) SRS product line	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
15/05/2009	21h16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
13/05/2009	23h22	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (S-8)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
13/05/2009	15h08	Marketwired	Wall Street News Alert: Morning Watch for Wednesday: ARWD - May 13, 2009	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
11/05/2009	22h44	PR Newswire (US)	Angiotech and Boston Scientific welcome journal article noting important differences between drug-eluting stent brands	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
08/05/2009	21h06	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
07/05/2009	17h45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)